Header Logo

Connection

Elliott Mufson to Alzheimer Disease

This is a "connection" page, showing publications Elliott Mufson has written about Alzheimer Disease.
Connection Strength

1.324
  1. Hippocampal proNGF signaling pathways and ?-amyloid levels in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol. 2012 Nov; 71(11):1018-29.
    View in: PubMed
    Score: 0.172
  2. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Arch Neurol. 2003 Aug; 60(8):1143-8.
    View in: PubMed
    Score: 0.090
  3. Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer's Disease. J Alzheimers Dis. 2023; 94(1):227-246.
    View in: PubMed
    Score: 0.087
  4. Co-expression network analysis of frontal cortex during the progression of Alzheimer's disease. Cereb Cortex. 2022 11 09; 32(22):5108-5120.
    View in: PubMed
    Score: 0.086
  5. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol. 2002 Feb 04; 443(2):136-53.
    View in: PubMed
    Score: 0.082
  6. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol. 2002 Feb; 51(2):145-55.
    View in: PubMed
    Score: 0.082
  7. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 2000 Nov 06; 427(1):19-30.
    View in: PubMed
    Score: 0.075
  8. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol. 1999 Aug; 158(2):469-90.
    View in: PubMed
    Score: 0.069
  9. Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology. J Clin Invest. 2018 10 01; 128(10):4297-4312.
    View in: PubMed
    Score: 0.064
  10. Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer's Disease. J Alzheimers Dis. 2015; 47(2):385-402.
    View in: PubMed
    Score: 0.050
  11. Evidence for Alzheimer's disease-linked synapse loss and compensation in mouse and human hippocampal CA1 pyramidal neurons. Brain Struct Funct. 2015 Nov; 220(6):3143-65.
    View in: PubMed
    Score: 0.048
  12. Cortical pyroglutamate amyloid-? levels and cognitive decline in Alzheimer's disease. Neurobiol Aging. 2015 Jan; 36(1):12-9.
    View in: PubMed
    Score: 0.048
  13. A novel approach for long-term oral drug administration in animal research. J Neurosci Methods. 2011 Feb 15; 195(2):194-9.
    View in: PubMed
    Score: 0.038
  14. Inability of plasma and urine F2A-isoprostane levels to differentiate mild cognitive impairment from Alzheimer's disease. Neurodegener Dis. 2010; 7(1-3):139-42.
    View in: PubMed
    Score: 0.036
  15. MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD. Neurobiol Aging. 2011 Oct; 32(10):1756-64.
    View in: PubMed
    Score: 0.035
  16. Cognitive performance correlates with cortical isopeptide immunoreactivity as well as Alzheimer type pathology. J Alzheimers Dis. 2008 Feb; 13(1):53-66.
    View in: PubMed
    Score: 0.031
  17. Activation of caspase-6 in aging and mild cognitive impairment. Am J Pathol. 2007 Apr; 170(4):1200-9.
    View in: PubMed
    Score: 0.029
  18. Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis. Neurology. 2007 Mar 06; 68(10):757-63.
    View in: PubMed
    Score: 0.029
  19. Nurr1 in Parkinson's disease and related disorders. J Comp Neurol. 2006 Jan 20; 494(3):495-514.
    View in: PubMed
    Score: 0.027
  20. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med. 2005 May; 11(5):551-5.
    View in: PubMed
    Score: 0.025
  21. Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease. Arch Neurol. 2005 Mar; 62(3):425-30.
    View in: PubMed
    Score: 0.025
  22. Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology. J Alzheimers Dis. 2003 Feb; 5(1):39-48.
    View in: PubMed
    Score: 0.022
  23. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann Neurol. 2002 Feb; 51(2):182-9.
    View in: PubMed
    Score: 0.020
  24. Improved detection of substantia nigra pathology in Alzheimer's disease. J Histochem Cytochem. 2002 Jan; 50(1):99-106.
    View in: PubMed
    Score: 0.020
  25. Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease. J Comp Neurol. 2001 Aug 27; 437(3):296-307.
    View in: PubMed
    Score: 0.020
  26. Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline. Neurosci Res. 2004 Jan; 48(1):93-100.
    View in: PubMed
    Score: 0.006
  27. Novel method to quantify neuropil threads in brains from elders with or without cognitive impairment. J Histochem Cytochem. 2000 Dec; 48(12):1627-38.
    View in: PubMed
    Score: 0.005
  28. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 1999 Sep 06; 411(4):693-704.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.